Clinical Management and Vitamin-Mineral Deficiencies in Children with Beta-Thalassemia Major: A Study on 112 Cases
Article Sidebar
Main Article Content
Abstract
Objective: Thalassemia major, an autosomal recessive genetic disorder, represents a significant healthcare concern worldwide. The hallmark of this condition is the deficiency in hemoglobin synthesis, resulting in chronic anemia and necessitating regular blood transfusions. This study endeavors to delve into the realm of pediatric patients afflicted by thalassemia major, with a particular focus on investigating potential vitamin and mineral deficiencies. By exploring these deficiencies, we aim to contribute to the broader understanding of the physiological implications of thalassemia major on growing individuals, shedding light on aspects that could impact their overall health and well-being.
Material Methods: The current study constitutes a retrospective analysis of a meticulously curated dataset comprising 112 pediatric patients diagnosed with thalassemia major. The patients were drawn from diverse backgrounds and were subjected to rigorous assessment and evaluation. Comprehensive medical records, encompassing demographic information, clinical history, and laboratory findings, were meticulously reviewed.
Results: The patients had a mean age of 8.14±12 years; among them, 59 (52.7%) were girls. The median hemoglobin and ferritin levels were 8.5 g/dL (range 6.5-10.6) and 2497 ml/ng (range 170-7417), respectively. The frequency of erythrocyte suspension (ES) transfusion in the patients was 1:2.7 weeks. The mean serum levels were 423.7 pg/mL (range 166-755) for vitamin B12, 6.6 ng/mL (range 1.55-16.4) for folic acid, 79.4 mg/dL (range 51-167) for zinc, and 111.07 mg/dL (range 67-190) for copper. Among the patients, 7 (6.25%) had a vitamin B12 deficiency, 35 (31.25%) had a folic acid deficiency, 27 (24.1%) had a zinc deficiency, and 10 (8.9%) had a copper deficiency.
Conclusion: The exploration into pediatric thalassemia major unveils a landscape where folic acid and zinc deficiencies play a significant role. The detected prominence of these deficiencies prompts a call for focused interventions to address the potential health implications. Amid the intricate fabric of thalassemia major, the spotlight on folic acid and zinc deficiencies highlights an avenue for proactive healthcare strategies. By targeting these deficiencies, we hold the potential to improve the well-being and future prospects of young patients grappling with thalassemia major.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2023-07-30
Published 2023-08-08
References
Gümrük F, Altay Ç. Talasemiler. Katkı Pediatri Dergisi 1995; 4: 1456- 60.
Origa, R. β-Thalassemia. Genet. Med. 2017, 19, 609–19.
Benz EJ, Patricia J, Giardina JV. Thalassemia syndrome. In: Blood disease of infancy and childhood. The CV Mosby Company; Philadelphia 1995; p. 460-98.
Shah, FT, Sayani F, Trompeter S, Drasar E, Piga A. Challenges of blood transfusions in β-thalassemia. Blood Rev. 2019, 37, 100588.
Factor JM, Pottipati SR, Rappaport I, Rosner IK, Lesser ML, Giardrna PJ. Pulmonary function abnormalities in thalassemia major and the role of iron overload. Am J Respir Crit Care Med 1994; 149: 1570- 74.
Tai DYA, Wang YT, Li OY, Malk KH, Cheng HK. Lungs in thalassemia major patients receiving regular transffusion. Eur Respir J 1996; 9: 1389-94.
Ballas SK, Zeidan AM, Duong VH, Deveaux M, Heeney MM. The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic review. Am. J. Hematol. 2018 Jul;93(7):943-52.
Thompson AA, Walters MC, Kwiatkowski J, Rasko JE, Ribeil JA, Hongeng S, et al. Gene therapy in patients with transfusion-dependent β-thalassemia. N. Engl. J. Med. 2018, 378, 1479–93.
Marktel S, Scaramuzza S, Cicalese MP, Giglio F, Galimberti S, Lidonnici MR, et al. Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia. Nat. Med. 2019, 25, 234-41.
Frangoul H, Altshuler D, Cappellini MD, Chen YS, Domm J, Eustace BK, et al. CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. N. Engl. J. Med. 2021 Jan 21; 384(3):252-260.
Jonathan JMP, Swann R. Metabolic phenotyping of malnutrition during the first 1000 days of life Eur J Nutr. 2019 Apr;58(3):909-930.
American Academy of Pediatrics. Trace elements. In: Kleinman RE, editor. Pediatric nutrition handbook, 6th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009. pp. 423–31.
National Institutes of Health Office of Dietary Supplements. Zinc: fact sheet for health professionals. http://ods.od.nih. gov/factsheets/Zinc-HealthProfessional/. [Accessed 14 April 2014].
Bailey RL, West KP Jr, Black RE. The epidemiology of global micronutrient defi ciencies. Ann Nutr Metab 2015;66(2):22-33.
Underwood BA. Perspectives from micronutrient malnutrition elimination/eradication programmes.
Akbay HI, Huyut Z, Çokluk E, Alp HH, Batur T, Şekeroğlu MR, et al. Copper and Zinc Levels in Individuals with Different Diseases According to Pre-diagnosis. Van Sag Bil Derg 2020; 13(2):24-30.
Green R, Allen LH, Bjørke-Monsen A, Brito A, Guéant JL, Miller JW, et al. Vitamin B12 deficiency. Nat Rev Dis Primers 2017 Jun 29;3:17040.
Sijilmassi O. Folic acid deficiency and vision: a review. Graefes Arch Clin Exp Ophthalmol 2019 Aug; 257(8):1573-80.
Doğan M. Zinc deficiency and excess. Klinik Tıp Pediatri Dergisi 2020; 12(1):13-9.
Myint ZW, Oo TH, Thein KZ, Tun AM, Saeed H.Copper deficiency anemia: review article. Ann Hematol 2018 Sep;97(9):1527-34.
Balcı YI, Akın M, Acun A. Plazma vitamin b12 and folic acid levels in patients with beta-thalassemia major. Türkiye Çocuk Hast. Derg./Turkish J. Pediatr. Dis. 2010;4(1):18-21.
Hannibal L, Lysne V, Bjørke-Monsen AL, Behringer S, Grünert SC, Spiekerkoetter U, et al. Biomarkers and algorithms for the diagnosis of vitamin b12 deficiency. Front Mol Biosci. 2016 Jun 27; 3:27.
Green R, Mitra AD. Megaloblastic anemias: Nutritional and other causes. Medical Clinics of North America. 2017 Mar;101(2):297-317.
Wazir SM, Ghobrial İ . Copper deficiency, a new triad: anemia, leucopenia and myeloneuropathy. J Community Hosp Intern Med Perspect 2017 Sep 19;7(4):265-8.
Cekic S, Karakas Z, Yalın K, Bilge AK, Omeroglu RE. Talasemi majorlu hastalarda QT dispersiyonu ve kalp hızı değişkenliğinin ferritin ile İlişkisi: Yüksek ferritin kalp demir yükünden çok sempatovagal disregulasyonu mu gösteriyor? Çocuk Dergisi 2012;12(3):125-31.
Salvatte K, Farias DR, Normando P, Berti TL, Castro IRR, Kac G. High serum folate concentration, vitamin b12 deficiency, and anthropometric nutritional status in brazilian children aged 6–59 months: Data from the Brazilian national survey of child nutrition. J Nutr. 2023 Jul;153(7):2094-104.
Nama AR, Hussein WH, Saleh SS. Relationships of vitamin d and vitamin b12 with malonaldehyde in patients with beta thalassemia major. Journal of Namibian Studies Journal of Namibian Studies, 2023; 33(2):4172–90.
Mbunga BK, Engebretsen IMS, Strand TA, Gjengdal ELF, Akilimali PZ, Langfjord MM, et al. Distribution and determinants of serum zinc, copper, and selenium levels among children under five years from Popokabaka, Democratic Republic of Congo: A Cross-Sectional Study. Nutrients 2022, 14(3), 683.
Hasan BK, Saud WH. Zinc and copper in transfusion-dependent thalassemia patients on different iron chelators in basrah: A case-control study. Medical Journal of Babylon May 7, 2023; 20(1),124-9.
Ali AM, Kalioby ME, Khashana A, Azab MA, Elfiky MA, Sayed HE. Role of zinc supplementation in improving bone density in late childhood patients with beta thalassemia major. Eur. Chem. Bull. 2023; 12(6),6480– 92.